Midostaurin in patients with indolent systemic mastocytosis: An open-label phase 2 trial

Publication date: September 2018

Source: Journal of Allergy and Clinical Immunology, Volume 142, Issue 3

Author(s): Bjorn van Anrooij, Joanne N.G. Oude Elberink, Lambert F.R. Span, Jan G.R. de Monchy, Stefano Rosati, André B. Mulder, Johanna C. Kluin-Nelemans

https://ift.tt/2MP8fQN